Company page
Galectin Therapeutics Inc.
Galectin Therapeutics Inc. is a public company traded under the ticker GALT in the American market. The company has a market capitalization of approximately $186 million. Galectin Therapeutics focuses on developing therapies for fibrotic diseases and cancer.
- Ticker
- GALT:NASDAQ
- Asset type
- Stock
- Market cap
- $186.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD